-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dabrafenib Mesylate in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dabrafenib Mesylate in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dabrafenib Mesylate in Refractory Multiple Myeloma Drug Details: Dabrafenib...
-
Product Insights
NewCardiac Ablation Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Market Report Overview Cardiac ablation devices use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The cardiac ablation devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Osteoarthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in Osteoarthritis Drug Details: Pentosan polysulfate sodium (PPS) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pentosan Polysulfate Sodium in Osteoarthritis Pain
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pentosan Polysulfate Sodium in Osteoarthritis Pain Drug Details: Pentosan polysulfate sodium (PPS) is under development...
-
Product Insights
Carotid and Renal Artery Stents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Carotid and Renal Artery Stents Pipeline Market Report Overview Carotid artery stents are expandable tubes that are implanted in narrowed carotid arteries to increase the flow of blood. Likewise, renal artery stents are expandable tubes that are implanted to increase blood flow in the narrowed renal artery. The Carotid and Renal Artery Stents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBL-949 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBL-949 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MBL-949 in Obesity Drug Details:MBL-949 is under development for the treatment of obese participants...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ION-547 in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ION-547 in Thrombosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.ION-547 in Thrombosis Drug Details:ION-547 is under development for the treatment of thrombosis. It...
-
Product Insights
Ophthalmic Diagnostic Equipment Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ophthalmic Diagnostic Equipment Pipeline Market Report Overview Ophthalmic diagnostic equipment helps in examining the eye for study purposes as well as for the treatment of different pathologies of the eye. The Ophthalmic Diagnostic Equipment pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the...
-
Sector Analysis
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Myasthenia Gravis Market Overview The Myasthenia Gravis (MG) market size for the seven major markets (7MM) was $3 billion in 2022. The market will register a CAGR of more than 8% during 2022-2032. MG is the most common neuromuscular disorder, although it is still classified as a rare disease. It is an autoimmune and neuromuscular disease that is characterized by muscle weakness and fatigue. In most patients, the disease is initially localized and limited to the eye muscles. This weakness...